Clinical Trials in Arizona

Showing 12441-12460 of 16,770 trials

Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors

NCT01129349

To evaluate the safety and tolerability of Oprozomib in patients with advanced refractory or recurrent solid tumors including determination of its Dose Limiting Toxicity (DLT) and Maximum Tolerated Dose (MTD) To determine the pharmacokinetics (PK) of Oprozomib To explore the anti-tumor activity of Oprozomib in this patient population including the overall response rate (ORR), the duration of responses (DOR), the progression-free survival (PFS) and time to progression (TTP) To define the pharmacodynamics (PDn) of Oprozomib.

Solid Tumors

Amgen44 participantsStarted Apr 2010

Scottsdale, Arizona, United States • Nashville, Tennessee, United States • San Antonio, Texas, United States

COMPLETEDPhase 231 miles

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

NCT00530816

To evaluate the best overall response rate, safety and tolerability of carfilzomib in patients with relapsed or refractory multiple myeloma.

Multiple Myeloma

Amgen164 participantsStarted Sep 2007

Scottsdale, Arizona, United States • Beverly Hills, California, United States • Laguna Hills, California, United States +27 more locations

Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors

Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma

Find Trials by Condition in Arizona

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma

Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain

Educational Program for Various Health Literacy Levels to Improve the Health of Individuals With Heart Failure

Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration

Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis

Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)